Literature DB >> 23151457

Perturbations in the HDL metabolic pathway predispose to the development of osteoarthritis in mice following long-term exposure to western-type diet.

I-E Triantaphyllidou1, E Kalyvioti, E Karavia, I Lilis, K E Kypreos, D J Papachristou.   

Abstract

OBJECTIVE: Recent data suggest that obesity and related metabolic aberrations are associated with osteoarthritis (OA) development, a phenomenon that is attributed at least in part to the consumption of lipid-rich diets. To date, the molecular mechanisms that govern the lipid-OA connection remain largely unknown. Given the important role of high-density lipoprotein (HDL) in plasma and tissue lipid metabolism, the main purpose of the present study was to investigate the role of HDL metabolism in the pathobiology of OA.
METHODS: We used apolipoprotein A-I (apoA-I)(-/-) mice that lack classical apoA-I containing HDL, LCAT(-/-) mice that have only immature HDL and relatively reduced HDL-cholesterol levels and control C57BL/6 mice. Mice were placed on chow or western-type (WTD) and monitored for 24 weeks. Knee joints were removed and articular cartilage was isolated for further analyses.
RESULTS: The LCAT(-/-) mice were significantly more sensitive to the development of diet-induced obesity compared to the C57BL/6 and apoA-I(-/-) mice. Morphological, biochemical and molecular analyses revealed that the LCAT(-/-) obese mice developed OA, while the C57BL/6 mice that were fed WTD did not. Notably, apoA-I(-/-) mice that received WTD also developed OA although their body-weight gain was similar to their wild-type counterparts. Interestingly, bone marrow from LCAT(-/-) and apoA-I(-/-) mice contained significantly increased number of adipocytes, compared to the other groups.
CONCLUSIONS: Our findings suggest that perturbations in HDL metabolism predispose to OA following chronic insult with WTD and raise the challenging possibility that HDL has a causative relation to OA in patients with metabolic syndrome.
Copyright © 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23151457     DOI: 10.1016/j.joca.2012.11.003

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  28 in total

Review 1.  High-density lipoprotein (HDL) metabolism and bone mass.

Authors:  Nicholaos I Papachristou; Harry C Blair; Kyriakos E Kypreos; Dionysios J Papachristou
Journal:  J Endocrinol       Date:  2017-03-17       Impact factor: 4.286

2.  Bone and high-density lipoprotein: The beginning of a beautiful friendship.

Authors:  Dionysios J Papachristou; Harry C Blair
Journal:  World J Orthop       Date:  2016-02-18

3.  Apolipoprotein A-1 regulates osteoblast and lipoblast precursor cells in mice.

Authors:  Harry C Blair; Elena Kalyvioti; Nicholaos I Papachristou; Irina L Tourkova; Spryros A Syggelos; Despina Deligianni; Malvina G Orkoula; Christos G Kontoyannis; Eleni A Karavia; Kyriakos E Kypreos; Dionysios J Papachristou
Journal:  Lab Invest       Date:  2016-04-18       Impact factor: 5.662

4.  Use of thiazolidinediones and the risk of elective hip or knee replacement: a population based case-control study.

Authors:  Johannes T H Nielen; Frank de Vries; Pieter C Dagnelie; Bart J F van den Bemt; Pieter J Emans; Arief Lalmohamed; Anthonius de Boer; Annelies Boonen
Journal:  Br J Clin Pharmacol       Date:  2015-11-04       Impact factor: 4.335

5.  Novel effects of sarcopenic osteoarthritis on metabolic syndrome, insulin resistance, osteoporosis, and bone fracture: the national survey.

Authors:  S M Chung; M H Hyun; E Lee; H S Seo
Journal:  Osteoporos Int       Date:  2016-05-13       Impact factor: 4.507

Review 6.  Novel Insights into Osteoarthritis Joint Pathology from Studies in Mice.

Authors:  Paxton M Moon; Frank Beier
Journal:  Curr Rheumatol Rep       Date:  2015-08       Impact factor: 4.592

7.  Apolipoprotein a-I at the interface of vascular inflammation and arthritis.

Authors:  Robert Terkeltaub
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-03       Impact factor: 8.311

Review 8.  Review: Metabolic Regulation of Inflammation in Osteoarthritis.

Authors:  Francis Berenbaum; Timothy M Griffin; Ru Liu-Bryan
Journal:  Arthritis Rheumatol       Date:  2017-01       Impact factor: 10.995

9.  Statin use and knee osteoarthritis progression: Results from a post-hoc analysis of the SEKOIA trial.

Authors:  Florent Eymard; Camille Parsons; Mark H Edwards; Florence Petit-Dop; Jean-Yves Reginster; Olivier Bruyère; Xavier Chevalier; Cyrus Cooper; Pascal Richette
Journal:  Joint Bone Spine       Date:  2017-10-14       Impact factor: 4.929

10.  Association of Serum Low-Density Lipoprotein, High-Density Lipoprotein, and Total Cholesterol With Development of Knee Osteoarthritis.

Authors:  Jessica L Schwager; Michael C Nevitt; James Torner; Cora E Lewis; Nirupa R Matthan; Na Wang; Xianbang Sun; Alice H Lichtenstein; David Felson
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-01-08       Impact factor: 4.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.